XML 14 R5.htm IDEA: XBRL DOCUMENT v3.22.4
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
Common Stock
Additional Paid in Capital
Accumulated Other Comprehensive Income
Retained Earnings
Total
Balance at Mar. 31, 2021 $ 2,949 $ 8,944,660 $ 21,838 $ 972,401 $ 9,941,848
Balance (in shares) at Mar. 31, 2021 29,498,662        
Stock-based compensation   33,500     33,500
Net income (loss)       1,371,092 1,371,092
Foreign currency translation adjustment     42   42
Balance at Jun. 30, 2021 $ 2,949 8,978,160 21,880 2,343,493 11,346,482
Balance (in shares) at Jun. 30, 2021 29,498,662        
Balance at Mar. 31, 2021 $ 2,949 8,944,660 21,838 972,401 9,941,848
Balance (in shares) at Mar. 31, 2021 29,498,662        
Net income (loss)         300,000
Balance at Mar. 31, 2022 $ 3,430 14,637,771   622,567 15,263,768
Balance (in shares) at Mar. 31, 2022 34,307,450        
Balance at Jun. 30, 2021 $ 2,949 8,978,160 21,880 2,343,493 11,346,482
Balance (in shares) at Jun. 30, 2021 29,498,662        
Restricted stock award $ 10 (10)      
Restricted stock award (in shares) 100,000        
Common stock issued for acquired business $ 147 2,268,853     2,269,000
Common stock issued for acquired business (shares) 1,466,061        
Proceeds from sale of common stock, net $ 320 3,187,261     3,187,581
Proceeds from sale of common stock, net (in shares) 3,202,727        
Issuance of warrants   46,256     46,256
Stock-based compensation   28,566     28,566
Net income (loss)       (220,413) (220,413)
Foreign currency translation adjustment     (1,141)   (1,141)
Balance at Sep. 30, 2021 $ 3,426 14,509,086 20,739 2,123,080 16,656,331
Balance (in shares) at Sep. 30, 2021 34,267,450        
Issuance of common stock $ 2 34,998     35,000
Issuance of common stock (in shares) 20,000        
Stock-based compensation   44,109     44,109
Net income (loss)       (904,680) (904,680)
Foreign currency translation adjustment     (810)   (810)
Balance at Dec. 31, 2021 $ 3,428 14,588,193 $ 19,929 1,218,400 15,829,950
Balance (in shares) at Dec. 31, 2021 34,287,450        
Balance at Mar. 31, 2022 $ 3,430 14,637,771   622,567 15,263,768
Balance (in shares) at Mar. 31, 2022 34,307,450        
Stock-based compensation   52,107     52,107
Net income (loss)       (501,165) (501,165)
Balance at Jun. 30, 2022 $ 3,430 14,689,878   121,402 14,814,710
Balance (in shares) at Jun. 30, 2022 34,307,450        
Balance at Mar. 31, 2022 $ 3,430 14,637,771   622,567 15,263,768
Balance (in shares) at Mar. 31, 2022 34,307,450        
Net income (loss)         100,000
Balance at Sep. 30, 2022 $ 3,444 14,936,713   512,346 15,452,503
Balance (in shares) at Sep. 30, 2022 34,443,959        
Balance at Jun. 30, 2022 $ 3,430 14,689,878   121,402 14,814,710
Balance (in shares) at Jun. 30, 2022 34,307,450        
Stock-based compensation   46,539     46,539
Stock issued for contingent consideration $ 4 56,306     56,310
Stock issued for contingent consideration (in shares) 36,509        
Stock award nonemployee directors $ 10 143,990     144,000
Stock award nonemployee directors (in shares) 100,000        
Net income (loss)       390,944 390,944
Balance at Sep. 30, 2022 $ 3,444 14,936,713   512,346 15,452,503
Balance (in shares) at Sep. 30, 2022 34,443,959        
Stock-based compensation   8,663     8,663
Net income (loss)       133,975 133,975
Balance at Dec. 31, 2022 $ 3,444 $ 14,945,376   $ 646,321 $ 15,595,141
Balance (in shares) at Dec. 31, 2022 34,443,959